Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches
-
Published:2023-06
Issue:
Volume:114
Page:154796
-
ISSN:0944-7113
-
Container-title:Phytomedicine
-
language:en
-
Short-container-title:Phytomedicine
Author:
Zhang Ya-Ni, Zhu Guang-HaoORCID, Liu Wei, Xiong Yuan, Hu Qing, Zhuang Xiao-Yu, Jia Gui-Hua, Zhang Wei-Dong, Ge Guang-Bo
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference30 articles.
1. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: a review;Adhikari;Phytother. Res.,2021 2. Peptide substrate screening for the diagnosis of SARS-CoV-2 using fluorescence resonance energy transfer (FRET) assay;Alhadrami;Mikrochim. Acta,2021 3. Targeted covalent inhibitors for drug design;Baillie;Angew. Chem. Int. Ed Engl.,2016 4. Research progress on biological activity of sciadopitysin;Zuo;Med. Plant.,2021 5. Boras, B., Jones, R.M., Anson, B.J., Arenson, D., Aschenbrenner, L., Bakowski, M.A., Beutler, N., Binder, J., Chen, E., Eng, H., Hammond, H., Hammond, J., Haupt, R.E., Hoffman, R., Kadar, E.P., Kania, R., Kimoto, E., Kirkpatrick, M.G., Lanyon, L., Lendy, E.K., Lillis, J.R., Logue, J., Luthra, S.A., Ma, C., Mason, S.W., McGrath, M.E., Noell, S., Obach, R.S., O'Brien, M.N., O'Connor, R., Ogilvie, K., Owen, D., Pettersson, M., Reese, M.R., Rogers, T.F., Rossulek, M.I., Sathish, J.G., Shirai, N., Steppan, C., Ticehurst, M., Updyke, L.W., Weston, S., Zhu, Y., Wang, J., Chatterjee, A.K., Mesecar, A.D., Frieman, M.B., Anderson, A.S., Allerton, C., 2021. Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19. bioRxiv.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|